Stability of blood clotting products in ambulances under real-world conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study monitors the stability of human fibrinogen concentrates and lyophilized plasma (Octaplas) stored in ground-based EMS ambulances under routine operating conditions during summer. Samples are collected and analyzed monthly over four months and compared with reference samples kept under manufacturer-recommended conditions. Temperature inside storage containers and the vehicle is continuously tracked to identify any environmental factors linked to stability changes. The aim is to determine if common prehospital storage practices affect product quality and if current procedures should be adjusted.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Fibryga samples stored in the participating ground-based EMS ambulance.
* Octaplas LG AB samples stored in the participating ground-based EMS ambulance.
* Samples available for laboratory analysis at the predefined study time points.
* Samples exposed to routine operational storage conditions during the study period.

Exclusion Criteria:

* Samples with damaged packaging.
* Samples with incomplete storage documentation.
* Samples accidentally removed from the designated storage system during the observation period.
* Samples unavailable for laboratory analysis.
* Samples exposed to conditions not representative of routine EMS operation.

Where it's running

• Medical University of Graz
  Graz, Austria Recruiting

Study contacts

• Study coordinator: Maximilian Niederer, MD
• Email: maximilian.niederer@medunigraz.at
• Phone: 0316385081237

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage

  This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.

  Recruiting at 3 sites Phase 4 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 2 other locations · NCT07869537

• Rapid bedside fibrinogen testing for bleeding trauma patients in the emergency department

  This will test a rapid bedside fibrinogen test for adults with traumatic bleeding to help decide who needs fibrinogen replacement.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT07097337

• Using ROTEM analysis to improve outcomes in sepsis and trauma patients

  This study is testing if a special blood test can help doctors spot early signs of serious blood clotting issues in patients with sepsis or trauma to improve their treatment.

  Recruiting Region Stockholm · Stockholm · NCT06891599

• Empiric prehospital transfusion bundle for traumatic haemorrhagic shock

  We will try giving fibrinogen, plasma, and tranexamic acid before hospital arrival to adults with suspected life‑threatening bleeding from trauma to see if outcomes and safety change.

  Recruiting Medical University of Graz · Graz · NCT06891131

• Using tranexamic acid to treat traumatic bleeding with real-time monitoring

  This study tests whether giving tranexamic acid in a new way, based on real-time blood monitoring, can help patients with severe trauma stop bleeding better and reduce the risk of complications.

  Recruiting Phase 4 Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT06736860

• Using a special tourniquet for severe abdominal bleeding in trauma patients

  This study is testing a special tourniquet to see if it can help trauma patients with severe abdominal bleeding in emergency situations.

  Recruiting Medical University of Graz · Graz, Styria · NCT06622317

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.